Implante valvular aórtico transarterial: experiencia en Chile

Background: Transcatheter aortic valve implantation (TAVI) is taking a leading role in the management of patients with severe aortic stenosis. Valve replacement surgery prolongs survival and is the technique of choice considering its historical background and long experience worldwide. Recently howe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Caorsi,Carlos, Baeza,Cristian, Morís,César, Oyonarte,Miguel, Venegas,Juan Carlos, Yovanovich,Jorge, Rufs,Jorge, Díaz,Rodrigo, Espíndola,Manuel
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2013
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000100001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872013000100001
record_format dspace
spelling oai:scielo:S0034-988720130001000012013-05-23Implante valvular aórtico transarterial: experiencia en ChileCaorsi,CarlosBaeza,CristianMorís,CésarOyonarte,MiguelVenegas,Juan CarlosYovanovich,JorgeRufs,JorgeDíaz,RodrigoEspíndola,Manuel Aortic valve replacement Aortic valve stenosis Balloon valvuloplasty Background: Transcatheter aortic valve implantation (TAVI) is taking a leading role in the management of patients with severe aortic stenosis. Valve replacement surgery prolongs survival and is the technique of choice considering its historical background and long experience worldwide. Recently however, TAVI has positioned itself as the only standard therapy for symptomatic patients who are not candidates for surgery. Aim: To report the experience with this new technique comparing our results with those reported in the literature. Material and Methods: Between May 2010 and December 2011,17patients aged 81 ± 7.3 years (58.8% men with an Euro SCORE 29 ± 22.4%) underwent a TAVI. Results: The median transvalvular gradient was 54 ± 15.7 mmHg. All patients received a CoreValveTM. Technical success was 100%, with a post implant gradient of 6.29 ± 3.3 mmHg. Residual aortic regurgita-tion was observed in 94%, none greater than grade II. There were no complications at the vascular access site. One patient developed cardiac tamponade during the procedure. Permanent pacemaker implantation was required in 35.2%. Hospital mortality rate was 5.8%, a figure that remained unchanged at 30 days offollow-up. Conclusions: In high-risk patients with aortic stenosis, TAVI has a high success rate and a low rate of complications. Besides an appropriate patient selection, a trained multidisciplinary team and technical conditions to solve possible complications of the procedure are required.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.141 n.1 20132013-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000100001es10.4067/S0034-98872013000100001
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Aortic valve replacement
Aortic valve stenosis
Balloon valvuloplasty
spellingShingle Aortic valve replacement
Aortic valve stenosis
Balloon valvuloplasty
Caorsi,Carlos
Baeza,Cristian
Morís,César
Oyonarte,Miguel
Venegas,Juan Carlos
Yovanovich,Jorge
Rufs,Jorge
Díaz,Rodrigo
Espíndola,Manuel
Implante valvular aórtico transarterial: experiencia en Chile
description Background: Transcatheter aortic valve implantation (TAVI) is taking a leading role in the management of patients with severe aortic stenosis. Valve replacement surgery prolongs survival and is the technique of choice considering its historical background and long experience worldwide. Recently however, TAVI has positioned itself as the only standard therapy for symptomatic patients who are not candidates for surgery. Aim: To report the experience with this new technique comparing our results with those reported in the literature. Material and Methods: Between May 2010 and December 2011,17patients aged 81 ± 7.3 years (58.8% men with an Euro SCORE 29 ± 22.4%) underwent a TAVI. Results: The median transvalvular gradient was 54 ± 15.7 mmHg. All patients received a CoreValveTM. Technical success was 100%, with a post implant gradient of 6.29 ± 3.3 mmHg. Residual aortic regurgita-tion was observed in 94%, none greater than grade II. There were no complications at the vascular access site. One patient developed cardiac tamponade during the procedure. Permanent pacemaker implantation was required in 35.2%. Hospital mortality rate was 5.8%, a figure that remained unchanged at 30 days offollow-up. Conclusions: In high-risk patients with aortic stenosis, TAVI has a high success rate and a low rate of complications. Besides an appropriate patient selection, a trained multidisciplinary team and technical conditions to solve possible complications of the procedure are required.
author Caorsi,Carlos
Baeza,Cristian
Morís,César
Oyonarte,Miguel
Venegas,Juan Carlos
Yovanovich,Jorge
Rufs,Jorge
Díaz,Rodrigo
Espíndola,Manuel
author_facet Caorsi,Carlos
Baeza,Cristian
Morís,César
Oyonarte,Miguel
Venegas,Juan Carlos
Yovanovich,Jorge
Rufs,Jorge
Díaz,Rodrigo
Espíndola,Manuel
author_sort Caorsi,Carlos
title Implante valvular aórtico transarterial: experiencia en Chile
title_short Implante valvular aórtico transarterial: experiencia en Chile
title_full Implante valvular aórtico transarterial: experiencia en Chile
title_fullStr Implante valvular aórtico transarterial: experiencia en Chile
title_full_unstemmed Implante valvular aórtico transarterial: experiencia en Chile
title_sort implante valvular aórtico transarterial: experiencia en chile
publisher Sociedad Médica de Santiago
publishDate 2013
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000100001
work_keys_str_mv AT caorsicarlos implantevalvularaorticotransarterialexperienciaenchile
AT baezacristian implantevalvularaorticotransarterialexperienciaenchile
AT moriscesar implantevalvularaorticotransarterialexperienciaenchile
AT oyonartemiguel implantevalvularaorticotransarterialexperienciaenchile
AT venegasjuancarlos implantevalvularaorticotransarterialexperienciaenchile
AT yovanovichjorge implantevalvularaorticotransarterialexperienciaenchile
AT rufsjorge implantevalvularaorticotransarterialexperienciaenchile
AT diazrodrigo implantevalvularaorticotransarterialexperienciaenchile
AT espindolamanuel implantevalvularaorticotransarterialexperienciaenchile
_version_ 1718436667635793920